rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Novartis India Ltd.

500672 NOVARTIND Group (B)

26 Jul,15:44
1156.00
17.75 (1.56%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Novartis India Ltd.

BUYSELL

13,993 1,138.25 1,180.00 - 1,127.10 1,224.00 - 599.95 2,855.33
NSE | BSE

Novartis India Ltd.

NOVARTIND

25 Oct,15:57
672.25
-17.10 (-2.48%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Novartis India Ltd.

BUYSELL

11,837 689.35 698.20 - 668.35 909.00 - 537.00 8,054,131.54

News for Novartis India Ltd.

Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15
Alembic Pharma...
Alembic Pharma Gets USFDA Nod for Heart Failure Drug
Alembic Pharmaceuticals receives USFDA approval to market a generic medication for heart failure, a therapeutically equivalent version of Novartis's Entresto tablets.
May 30, 2024 16:20
India's Growing...
India's Growing Appeal for Clinical Trials: Pharma Leaders Speak
Pharma industry leaders highlight India's rising attractiveness for clinical trials, citing recent reforms and a robust healthcare infrastructure. Learn about the factors driving this trend.
Apr 27, 2024 19:35
Novartis India Strategic Review: Impact on Listed Business
Novartis AG announces a strategic review of Novartis India Ltd, its listed subsidiary, assessing its 70.68% shareholding. The review does not impact Novartis Healthcare Pvt Ltd.
Feb 16, 2024 22:31
Novartis India Strategic Review: Future of Novartis India Ltd
Novartis AG announces a strategic review of Novartis India Ltd, including its 70.68% stake. The review will not affect Novartis Healthcare Pvt Ltd.
Feb 16, 2024 21:52

More News for Novartis India Ltd. »

(Rs. Crore)

Financial Results of Novartis India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales335.07378.74399.87381.35438.25
Operating profit65.2665.0827.1126.7912.03
Interest1.491.754.837.686.39
Gross profit125.45121.4455.4752.2041.78
EPS (Rs)34.5241.88-1.518.474.08

See more in Research Center »

News for Pharmaceuticals and health care

Aditya Birla...
Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue
Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...
Jul 26, 2024 22:32
Sebi Confirms...
Sebi Confirms Order Against 12 in V Marc India Fraud
Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.
Jul 26, 2024 22:25
PM GatiShakti...
PM GatiShakti Evaluates 5 Infra Projects: Road, Rail
Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.
Jul 26, 2024 22:10
Fortune Wealth...
Fortune Wealth Targets Rs 500 cr Multi-Cap Fund
Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.
Jul 26, 2024 22:05
Kargil Vijay...
Kargil Vijay Diwas: India Post Releases Commemorative Stamp
India Post commemorates the 25th anniversary of Kargil Vijay Diwas with a special postage stamp, honoring the bravery of Indian armed forces.
Jul 26, 2024 22:04

More News »

Top News

G20 Agrees to Tax...
G20 Agrees to Tax Super-Rich, Brazil Leads Effort
Finance ministers from G20 nations agree to work toward taxing the super-rich, a significant step toward addressing global inequality. Brazil's proposal for a 2% minimum tax on billionaires is...
Jul 27, 2024 03:35
Aditya Birla...
Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue
Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...
Jul 26, 2024 22:32
Sebi Confirms...
Sebi Confirms Order Against 12 in V Marc India Fraud
Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.
Jul 26, 2024 22:25
PM GatiShakti...
PM GatiShakti Evaluates 5 Infra Projects: Road, Rail
Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.
Jul 26, 2024 22:10
Fortune Wealth...
Fortune Wealth Targets Rs 500 cr Multi-Cap Fund
Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.
Jul 26, 2024 22:05

More Top News »

Report Card

PE Ratios
33.49
EPS (Rs.)
34.52
Sales (Rs. Cr)
81.17
Face Value (Rs.)
5
Net Profit Margin (%)
25.42
Last Bonus
1:2
Last Dividend(%)
500
Return on Average Equity
11.43

Compare 'Novartis India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,665.20
  • Compare
  • Divi's Laboratories Ltd.
  • 4,549.75
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,205.60
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,854.20
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,087.85
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,388.60
  • Compare
  • Max Healthcare Institute Ltd.
  • 926.50
  • Compare
  • Alkem Laboratories Ltd.
  • 5,178.80
  • Compare

Most Active

  • Change (Rs.)
  •  

Novartis India Ltd. performance snapshot

If you had invested Rs.  in Novartis India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Novartis India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Novartis India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close